Protective Effect of Prostaglandin EP4-Receptor Agonist on Anti-glomerular Basement Membrane Antibody-Associated Nephritis

10.1016/0020-711X(80)90070-1 2 Lianos EA, Andres GA, Dunn MJ. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics. J Clin Invest. 1983;72:1439–1448. 1985, 233, 672 4 Nagao T, Nagamatsu T, Suzuki Y. Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis. in rats. Eur J Pharmacol. 1998;384:37–44. 10.1016/S0090-6980(97)00145-7 6 Sugimoto Y, Namba T, Shigemoto R, Negishi M, Ichikawa A, Narumiya S. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol. 1994;266:F823–F828. 10.1254/jjp.85.139 NAGAMATSU T, 1989, 51, 521, 10.1254/jjp.51.521 10.1254/jjp.89.373 10.1038/sj.bjp.0705564 NAGAMATSU T, 1988, 46, 397, 10.1254/jjp.46.397 10.1016/S0014-2999(00)00932-8 13 Assmann KJ, van Son JP, Koene RA. Improved method for the isolation of mouse glomeruli. J Am Soc Nephol. 1991;2:944–946. 14 Mosquera JA. Increase production of fibronectin by glomerular cultures from rats with nephrotoxic nephritis. Macrophages induce fibronectin productin in cultured mesangial cells. Lab Invest. 1993;68:406–412. 1993, 268, 20175, 10.1016/S0021-9258(20)80710-8 10.1016/0014-5793(95)00966-D 1993, 268, 7759, 10.1016/S0021-9258(18)53022-2 10.1074/jbc.271.47.29569 19 Nagamatsu T, Nagao T, Hayashi K, Suzuki Y. Antiproteinuric effect of KD3-671, an angiotensin II type 1 receptor antagonist, in rats with accelerated passive Heymann nephritis. Jpn J Pharmacol. 2002;88:213–216. 1995, 25, 961 21 Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 1993;366:307–308. 10.1054/plef.2001.0327 23 Pearse DD, Pereira FC, Marcillo AE, Baters ML, Berrocal YA, FilbinIL MT, et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med. 2004;10:610–616. 24 Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuhi K. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci. 2002;47:894–904. 10.1073/pnas.062053399 26 Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T, et al. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation. 2004;109:2462–2468. 27 Nataraj C, Thomas DW, Tilley SL, Nguyen MT, Mannon R, Koller BH, et al. Receptors for prostaglandin E₂ that regulate cellular immune responses in the mouse. J Clin Invest. 2001;108:1229–1235. 28 Fennekohl A, Sugimoto Y, Segi E, Maruyama T, Ichikawa A, Puschel GP. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2- or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J Hepatol. 2002;36:328–334. 29 Timoshanko JR, Sedgwick JD, Holdworth SR, Tipping PG. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol. 2003;14:1785–1793. HATTORI T, 1994, 36, 1228 31 Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, et al. Prostaqglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol. 2004;41:251–258. NAGAMATSU T, 1997, 75, 381, 10.1254/jjp.75.381